Author

Marlena Maziarz

Lund University - Cited by 1,282 - Biostatistics - survival analysis - longitudinal data analysis - prediction

Biography

Dr.  Marlena Maziarz is an Associate professor in the Department of Biostatistics, University of Washington, Seattle, WA, USA. and his study interests major on emerging or re-emerging disease and the microbes-host interaction. In recent years, he has studied several viruses including HIV-1, human or avian influenza, dengue, and Zika viruses. Currently, Dr. Marlena Maziarz is the author/editor/reviewer in several international journals. He published 4 articles in many journals and the articles are informative and got good citations
Title
Cited by
Year
On longitudinal prediction with time‐to‐event outcome: comparison of modeling options
M Maziarz, P Heagerty, T Cai, Y ZhengBiometrics 73 (1), 83-93, 2017201
54
2017
Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS)
MA Rosenberg, M Maziarz, AY Tan, NL Glazer, SJ Zieman, JR Kizer, JH Ix, ...American heart journal 167 (5), 723-728. e2, 2014201
49
2014
Activation of enteroendocrine membrane progesterone receptors promotes incretin secretion and improves glucose tolerance in mice
GB Flock, X Cao, M Maziarz, DJ DruckerDiabetes 62 (1), 283-290, 2013201
46
2013
Plasma-free fatty acids, fatty acid–binding protein 4, and mortality in older adults (from the Cardiovascular Health Study)
MD Miedema, M Maziarz, ML Biggs, SJ Zieman, JR Kizer, JH Ix, ...The American journal of cardiology 114 (6), 8-848, 2014201
43
2014
Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY study
K Vehik, E Bonifacio, Å Lernmark, L Yu, A Williams, D Schatz, M Rewers, ...Diabetes Care 43 (9), 2066-2073, 2020202
41
2020
Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes
S García-Calzón, A Perfilyev, M Martinell, M Ustinova, S Kalamajski, ...Science translational medicine 12 (561), eaaz1803, 2020202
33
2020
Age and geographic patterns of Plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of …
M Maziarz, T Kinyera, I Otim, P Kagwa, H Nabalende, ID Legason, ...Malaria journal 16, 1-14, 2017201
30
2017
An age-related exponential decline in the risk of multiple islet autoantibody seroconversion during childhood
E Bonifacio, A Weiß, C Winkler, M Hippich, MJ Rewers, J Toppari, ...Diabetes Care 44 (10), 20-28, 2021202
26
2021
Anti-idiotypic antibody specific to GAD65 autoantibody prevents type 1 diabetes in the NOD mouse
X Wang, A Zhang, Y Liu, S Chen, Z Feng, W Shang, M Maziarz, J Radtke, ...PloS one 7 (2), e32515, 2012201
23
2012
Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
KM Gooding, C Lienczewski, M Papale, N Koivuviita, M Maziarz, ...BMC nephrology 21 (1), 1-11, 2020202
23
2020
Islet autoantibodies and residual beta cell function in type 1 diabetes children followed for 3–6 years
JS Sorensen, F Vaziri-Sani, M Maziarz, K Kristensen, A Ellerman, ...Diabetes research and clinical practice 96 (2), 204-210, 2012201
23
2012
A cross-sectional study of asymptomatic Plasmodium falciparum infection burden and risk factors in general population children in 12 villages in northern Uganda
M Maziarz, H Nabalende, I Otim, ID Legason, T Kinyera, MD Ogwang, ...Malaria journal 17 (1), 1-15, 2018201
22
2018
Serum ghrelin and esophageal and gastric cancer in two cohorts in China
NR Pritchett, M Maziarz, XO Shu, F Kamangar, SM Dawsey, JH Fan, BT Ji, ...International journal of cancer 146 (10), 2728-2735, 2020202
21
2020
Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies
M Maziarz, W Hagopian, JP Palmer, CB Sanjeevi, I Kockum, N Breslow, ...Genes & Immunity 16 (8), 541-551, 151
20
2015
Plasma free fatty acids and risk of stroke in the Cardiovascular Health Study
O Khawaja, M Maziarz, ML Biggs, WT Longstreth Jr, JH Ix, JR Kizer, ...International Journal of Stroke 9 (7), 9-920, 2014201
17
2014
Using standard microbiome reference groups to simplify beta-diversity analyses and facilitate independent validation
M Maziarz, RM Pfeiffer, Y Wan, MH GailBioinformatics 34 (19), 3249-3257, 2018201
16
2018
App-based COVID-19 syndromic surveillance and prediction of hospital admissions in COVID Symptom Study Sweden
B Kennedy, H Fitipaldi, U Hammar, M Maziarz, N Tsereteli, N Oskolkov, ...Nature Communications 13 (1), 2110, 202215202
15
2022
Evaluating risk of ESRD in the urban poor
M Maziarz, RA Black, CT Fong, J Himmelfarb, GM Chertow, YN HallJournal of the American Society of Nephrology: JASN 26 (6), 34, 2015201
14
2015
Homelessness and risk of end-stage renal disease
M Maziarz, GM Chertow, J Himmelfarb, YN HallJournal of health care for the poor and underserved 25 (3), 31, 2014201
12
2014
Risk prediction to inform surveillance of chronic kidney disease in the US Healthcare Safety Net: a cohort study
Y Xie, M Maziarz, DS Tuot, GM Chertow, J Himmelfarb, YN HallBMC nephrology 17 (1), 1-10, 2016201
12
2016

Referred From: https://scholar.google.com/citations?user=7_qd38sAAAAJ&hl=en

Cited by
Citations 1282
h-index 21
i10-index 30
Recommended Journals
Open Access Journals